Kalmar Investments’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
RC
BC
BFA
BIT
SAM
SFM
LAM
Kalmar Investments's ANGO Position: Q4 2015 in Review
Kalmar Investments sold out of AngioDynamics (ANGO) in Q4 2015, closing a stake of 420,004 shares — an estimated $5.54M sold.
Kalmar Investments first reported a position in ANGO in Q4 2014 and held it in 4 quarters. The position peaked at $10.5M in Q1 2015. 121 funds tracked by Wall St. Rank hold ANGO as of Q4 2015.
- Kalmar Investments reported no remaining AngioDynamics position as of Q4 2015 after selling out during the quarter.
- Kalmar Investments sold 420,004 AngioDynamics shares in Q4 2015, an estimated $5.54M.
- Kalmar Investments first reported a position in AngioDynamics in Q4 2014 and held it in 4 quarters.
- Kalmar Investments's AngioDynamics position peaked at $10.5M in Q1 2015.
- 121 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2015.
Based on Kalmar Investments's 13F filing for Q4 2015, filed 28 Jan 2016.